NO972642L - Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksin - Google Patents
Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksinInfo
- Publication number
- NO972642L NO972642L NO972642A NO972642A NO972642L NO 972642 L NO972642 L NO 972642L NO 972642 A NO972642 A NO 972642A NO 972642 A NO972642 A NO 972642A NO 972642 L NO972642 L NO 972642L
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- subunits
- protein analog
- bordetella exotoxin
- retain
- Prior art date
Links
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 title abstract 2
- 241000588807 Bordetella Species 0.000 title abstract 2
- 231100000776 exotoxin Toxicity 0.000 title abstract 2
- 239000002095 exotoxin Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9430787A | 1987-09-04 | 1987-09-04 | |
| US23248288A | 1988-08-17 | 1988-08-17 | |
| PCT/US1988/002983 WO1989001976A1 (en) | 1987-09-04 | 1988-08-26 | Recombinant dna-derived bordetella toxin subunit analogs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO972642D0 NO972642D0 (no) | 1997-06-09 |
| NO972642L true NO972642L (no) | 1997-07-28 |
| NO325016B1 NO325016B1 (no) | 2008-01-14 |
Family
ID=26788722
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO891842A NO301844B1 (no) | 1987-09-04 | 1989-05-03 | DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin |
| NO19972642A NO325016B1 (no) | 1987-09-04 | 1997-06-09 | Fremgangsmate for fremstilling av en proteinanalog til Bordetella-eksotoksin, polypeptidanalog av S1-subenhet fra Bordetella pertussis-toksin og vaksine mot pertussis. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO891842A NO301844B1 (no) | 1987-09-04 | 1989-05-03 | DNA-molekyl som koder for en polypeptidanalog til S1-underenheten i Bordetella-eksotoksin, og fremgangsmåte for fremstilling av en proteinanalog til S1-underenheten i Bordetella-eksotoksin |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5773600A (no) |
| EP (2) | EP0306318B2 (no) |
| JP (1) | JP2918895B2 (no) |
| KR (1) | KR0168039B1 (no) |
| CN (1) | CN1033866C (no) |
| AT (1) | ATE125568T1 (no) |
| CA (1) | CA1341560C (no) |
| DE (1) | DE3854213T3 (no) |
| DK (1) | DK175821B1 (no) |
| ES (1) | ES2076160T5 (no) |
| FI (1) | FI101632B1 (no) |
| GR (1) | GR3017497T3 (no) |
| IE (1) | IE69753B1 (no) |
| IL (3) | IL87608A0 (no) |
| NO (2) | NO301844B1 (no) |
| WO (1) | WO1989001976A1 (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925546A (en) * | 1987-11-02 | 1999-07-20 | Chiron S.P.A. | Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| US6713072B1 (en) * | 1987-11-02 | 2004-03-30 | Chiron S.R.L. | Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| IT1223334B (it) * | 1987-11-02 | 1990-09-19 | Sclavo Spa | Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse |
| US5332583A (en) * | 1987-11-24 | 1994-07-26 | Connaught Laboratories Limited | Vaccine containing genetically-detoxified pertussis holotoxin |
| US5358868A (en) * | 1987-11-24 | 1994-10-25 | Connaught Laboratories Limited | Genetic detoxification of pertussis toxin |
| GB8727489D0 (en) * | 1987-11-24 | 1987-12-23 | Connaught Lab | Detoxification of pertussis toxin |
| CA2009991A1 (en) * | 1989-02-15 | 1990-08-15 | Witold Cieplak | Pertussis toxin gene: cloning and expression of protective antigen |
| US7232671B2 (en) * | 1989-02-15 | 2007-06-19 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Pertussis toxin gene: cloning and expression of protective antigen |
| EP0396964B1 (en) * | 1989-04-28 | 1995-09-06 | SCLAVO S.p.A. | Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines |
| US5786189A (en) * | 1989-11-29 | 1998-07-28 | Smithkline Beecham Biologicals (S.A.) | Vaccine |
| GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| US20030072774A1 (en) * | 1994-06-10 | 2003-04-17 | Diane M. Gajewczyk | Proteinaceous adjuvants |
| EP1234580A1 (en) * | 1995-05-04 | 2002-08-28 | Aventis Pasteur Limited | Acellular Pertussis Vaccines and Methods of Preparation Thereof |
| WO1997043407A1 (en) * | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
| FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
| US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| CA2574953A1 (en) | 2004-07-26 | 2006-02-09 | Dow Global Technolgies Inc. | Process for improved protein expression by strain engineering |
| CA2590906C (en) * | 2004-12-17 | 2017-01-03 | Nvi Nederlands Vaccininstituut | Deacylation of lps in gram negative bacteria |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| WO2008134461A2 (en) | 2007-04-27 | 2008-11-06 | Dow Global Technologies, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| ITMI20090946A1 (it) | 2009-05-28 | 2010-11-29 | Novartis Ag | Espressione di proteine ricombinanti |
| MX343356B (es) | 2010-03-30 | 2016-11-03 | Pfenex Inc * | Toxinas proteicas recombinantes de alto nivel de expresion. |
| US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| AU2013301312A1 (en) | 2012-08-06 | 2015-03-19 | Glaxosmithkline Biologicals S.A. | Method for eliciting in infants an immune response against RSV and B. pertussis |
| MX362793B (es) | 2013-03-08 | 2019-02-13 | Janssen Vaccines & Prevention Bv | Vacuna acelular contra pertussis. |
| BE1022008B1 (fr) | 2013-08-05 | 2016-02-03 | Glaxosmithkline Biologicals S.A. | Compositions immunogenes combinees |
| CN109172818B (zh) * | 2018-08-02 | 2021-10-22 | 浙江康佰裕生物科技有限公司 | 一种蛋白牛痘疫苗及其效力检测方法 |
| US20220047690A1 (en) * | 2018-10-15 | 2022-02-17 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Vaccine polypeptide compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704362A (en) * | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| FR2590483B1 (fr) * | 1985-11-22 | 1988-12-09 | Pasteur Institut | Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant |
| CA1340373C (en) * | 1986-01-28 | 1999-02-02 | Rino Rappuoli | Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin |
| EP0275689B1 (en) * | 1986-12-23 | 1992-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Modified pertussis exotoxin |
| IT1223334B (it) * | 1987-11-02 | 1990-09-19 | Sclavo Spa | Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse |
| GB8727489D0 (en) * | 1987-11-24 | 1987-12-23 | Connaught Lab | Detoxification of pertussis toxin |
| IT1223529B (it) * | 1987-12-18 | 1990-09-19 | Sclavo Spa | Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse |
-
1988
- 1988-08-26 JP JP63507460A patent/JP2918895B2/ja not_active Expired - Lifetime
- 1988-08-26 WO PCT/US1988/002983 patent/WO1989001976A1/en active IP Right Grant
- 1988-08-26 KR KR1019890700803A patent/KR0168039B1/ko not_active IP Right Cessation
- 1988-08-30 IL IL87608A patent/IL87608A0/xx not_active IP Right Cessation
- 1988-08-30 IL IL10312188A patent/IL103121A/en not_active IP Right Cessation
- 1988-09-01 DE DE3854213T patent/DE3854213T3/de not_active Expired - Lifetime
- 1988-09-01 ES ES88308124T patent/ES2076160T5/es not_active Expired - Lifetime
- 1988-09-01 EP EP88308124A patent/EP0306318B2/en not_active Expired - Lifetime
- 1988-09-01 EP EP94109317A patent/EP0629696A1/en not_active Withdrawn
- 1988-09-01 AT AT88308124T patent/ATE125568T1/de not_active IP Right Cessation
- 1988-09-02 IE IE266888A patent/IE69753B1/en not_active IP Right Cessation
- 1988-09-02 CA CA 576469 patent/CA1341560C/en not_active Expired - Fee Related
- 1988-09-05 CN CN88107056A patent/CN1033866C/zh not_active Expired - Lifetime
-
1989
- 1989-05-03 NO NO891842A patent/NO301844B1/no not_active IP Right Cessation
- 1989-05-03 FI FI892131A patent/FI101632B1/fi not_active IP Right Cessation
- 1989-05-03 DK DK198902162A patent/DK175821B1/da active
-
1992
- 1992-09-09 IL IL103121A patent/IL103121A0/xx unknown
-
1995
- 1995-06-06 US US08/468,679 patent/US5773600A/en not_active Expired - Lifetime
- 1995-09-21 GR GR950402614T patent/GR3017497T3/el unknown
-
1997
- 1997-06-09 NO NO19972642A patent/NO325016B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO972642L (no) | Fremgangsmåte for fremstilling av en proteinanalog til Bordetella-eksotoksin | |
| KR100594787B1 (ko) | 경구용 백신 및 치료제의 전신 전달용 조성물 및 방법 | |
| ES2156110T3 (es) | Analogos de sub-unidades de toxina del colera derivados de adn recombinante. | |
| NO164177C (no) | Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon. | |
| MX9203458A (es) | Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano. | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| EP0855918A4 (en) | INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF | |
| ATE157258T1 (de) | Zubereitungen und behandlungen von pneumonia in tieren | |
| HK51597A (en) | Vaccines for human respiratory virus | |
| DE69533102D1 (de) | Analog von haemophilus hin47 mit verminderter protease aktivität | |
| MY101874A (en) | Vaccine | |
| DK0563254T3 (da) | Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner | |
| HK192695A (en) | The cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis | |
| NZ224251A (en) | Synthetic rhinovirus (hrv) peptides and vaccines | |
| Petersen et al. | Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin | |
| BURNETTE et al. | Pertussis Toxin SI Mutant with Reduced Enzyme Activity and a Conserved Protective Epitope |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |